This presentation from 'Drug Regulations' discusses the lifecycle approach to process validation in pharmaceuticals, emphasizing the significance of continuous process verification (CPV) throughout the manufacturing process. It covers the FDA and EMA guidelines on process validation, stages of process design, qualification, and ongoing verification, advocating for a systematic approach to ensure product quality and regulatory compliance. Practical insights into sampling strategies and data evaluation for CPV implementation are also provided.